Prescription Opioid Effects in Abusers Versus Non-Abusers

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

oxycodone 15 mg

15 mg/70 kg oxycodone administered once per day, orally.

DRUG

oxycodone 30 mg

30 mg/70 kg oxycodone administered once per day, orally.

DRUG

Placebo 0 mg

0 mg placebo dose administered once a day, orally.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00158184 - Prescription Opioid Effects in Abusers Versus Non-Abusers | Biotech Hunter | Biotech Hunter